Terminated NA INTERVENTIONAL 1-arm NCT01292122

Safety Study of VCT-01™ in Split-Thickness Skin Graft Donor Site Wounds

A Single-Center, Prospective, Randomized Study of VCT-01™ in Split-Thickness Skin Graft Donor Site Wounds

Sponsor: Organogenesis

Conditions Wounds

Interventions VCT-01

Updated 5 times since 2017 Last updated: Dec 19, 2012 Started: Jun 30, 2011 Primary completion: Sep 30, 2012 Completion: Sep 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Organogenesis

See all terminations from Organogenesis

Other Wounds trials with similar outcome

Browse all Wounds trials

A NA clinical study on Wounds, this trial is terminated or withdrawn. The trial is conducted by Organogenesis and has accumulated 5 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA
Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

Jun 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Organogenesis

Data source: Organogenesis

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Edmonton, Canada